1 Introduction Immunotherapy has achieved notable success in clinical practice with the development of various immunogenic therapeutic agents [1-4]. However, its efficacy is often constrained by the immunosuppressive tumor microenvironment. In recent years, the cyclic GMP–AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling pathway has emerged as a key mediator of immunogenic responses, offering considerable potential to enhance antitumor immunity.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yao
Contact Yao, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack